Nucleus Software Exports Limited
Nucleus Software Exports Limited Fundamental Analysis
Nucleus Software Exports Limited (NUCLEUS.BO) shows moderate financial fundamentals with a PE ratio of 14.36, profit margin of 16.70%, and ROE of 18.41%. The company generates $8.8B in annual revenue with weak year-over-year growth of 0.70%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 59.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze NUCLEUS.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentNUCLEUS.BO demonstrates superior asset utilization.
Valuation Score
ExcellentNUCLEUS.BO trades at attractive valuation levels.
Growth Score
WeakNUCLEUS.BO faces weak or negative growth trends.
Financial Health Score
ExcellentNUCLEUS.BO maintains a strong and stable balance sheet.
Profitability Score
ModerateNUCLEUS.BO maintains healthy but balanced margins.
Key Financial Metrics
Is NUCLEUS.BO Expensive or Cheap?
P/E Ratio
NUCLEUS.BO trades at 14.36 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, NUCLEUS.BO's PEG of -1.62 indicates potential undervaluation.
Price to Book
The market values Nucleus Software Exports Limited at 2.49 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 11.17 times EBITDA. This signals the market has high growth expectations.
How Well Does NUCLEUS.BO Make Money?
Net Profit Margin
For every $100 in sales, Nucleus Software Exports Limited keeps $16.70 as profit after all expenses.
Operating Margin
Core operations generate 17.06 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.41 in profit for every $100 of shareholder equity.
ROA
Nucleus Software Exports Limited generates $11.95 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Nucleus Software Exports Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Nucleus Software Exports Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
NUCLEUS.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
14.36
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-1.62
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.49
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.40
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.009
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.68
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.18
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.16
vs 25 benchmark
How NUCLEUS.BO Stacks Against Its Sector Peers
| Metric | NUCLEUS.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 14.36 | 35.62 | Better (Cheaper) |
| ROE | 18.41% | 1160.00% | Weak |
| Net Margin | 16.70% | -136515.00% (disorted) | Strong |
| Debt/Equity | 0.01 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 1.68 | 4.79 | Neutral |
| ROA | 11.95% | -311498.00% (disorted) | Strong |
NUCLEUS.BO outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Nucleus Software Exports Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
74.80%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
100.37%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
120.95%
Industry Style: Growth, Innovation, High Beta
High Growth